Related Experiment Video

Updated: May 6, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

7.6K

Evaluation of 4DryField® as an Adhesion Prophylaxis in Pediatric Patients: A Propensity-Score Matched Study

Michaela Klinke1, Nina Dietze1, Tina Trautmann1

  • 1Department of Pediatric Surgery, University Medical Centre Mannheim, Mannheim, Baden-Württemberg, Germany.

European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie
|June 7, 2024
PubMed

Insights

4DryField® did not reduce adhesion formation in pediatric surgery patients. The treatment group experienced significantly more complications, including fever and elevated C-reactive protein (CRP) levels, indicating potential safety concerns.

Area of Science:

  • Pediatric Surgery
  • Adhesion Prevention
  • Surgical Complications

Background:

  • Abdominal adhesions post-surgery cause significant morbidity in children, including intestinal obstruction and pain.
  • Current treatments focus on barrier agents, with limited molecular therapies targeting adhesion formation.
  • 4DryField® has demonstrated efficacy in adults, prompting investigation in pediatric populations.

Purpose of the Study:

  • To evaluate the efficacy and safety of 4DryField® in preventing abdominal adhesions in pediatric surgical patients.
  • To compare adhesion recurrence rates and complication profiles between pediatric patients treated with 4DryField® and a control group.

Main Methods:

  • Retrospective analysis of pediatric laparotomy cases between January 2018 and February 2022.
  • Comparison of outcomes between 4DryField® treated group and a propensity score-matched control group.
  • Assessment of key endpoints: surgical revision, adhesion recurrence, infections, fever, C-reactive protein (CRP), and time to gastrointestinal passage.

Main Results:

  • 82 pediatric patients (43 4DryField®, 39 control) were analyzed after propensity score matching.
  • 4DryField® did not significantly impact adhesion readhesion rates.
  • The 4DryField® group exhibited a higher incidence of complications (47% vs. 15%), fever, and elevated CRP levels (p=0.002).

Conclusions:

  • 4DryField® demonstrated no benefit in reducing adhesion formation in pediatric patients.
  • The use of 4DryField® was associated with a significant increase in postoperative complications.
  • Further prospective studies are essential to ascertain the safety and efficacy of 4DryField® in pediatric surgical care.
Abstract

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K

Related Concept Videos

Adhesion01:14

Adhesion

Adhesion occurs when one type of molecule is attracted to a different molecule. Water exhibits adhesive properties in the presence of polar surfaces, such as glass or cellulose in plants. For instance, when water is poured into a glass, the positively charged hydrogen molecules of water are more attracted to the negatively charged oxygen molecules in the silica than to the oxygen in neighboring water molecules.
Capillary action is a result of water’s adhesive tendencies. When a narrow...
37.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414